Publication list - Publika - Scientific publications from Oslo University Hospital

Publications by Ellen Schlichting

109 publications found

Original articles

Skjerven HK, Danielsen AS, Schlichting E, Sahlberg KK, Hofvind S (2022)
Treatment of Ductal Carcinoma in situ: A Register-Based Study of Norwegian Women Diagnosed between 1995 and 2018
Breast Care (Basel), 17 (5), 486-494
DOI 10.1159/000524564, PubMed 36684407

Nilssen Y, Brustugun OT, Eriksen MT, Guren MG, Haug ES, Naume B, Schlichting E, Møller B (2022)
Compliance with recommended cancer patient pathway timeframes and choice of treatment differed by cancer type and place of residence among cancer patients in Norway in 2015-2016
BMC Cancer, 22 (1), 220
DOI 10.1186/s12885-022-09306-9, PubMed 35227226

Strømsvik N, Olsson P, Gravdehaug B, Lurås H, Schlichting E, Jørgensen K, Wangensteen T, Vamre T, Heramb C, Mæhle L, Grindedal EM (2022)
"It was an important part of my treatment": a qualitative study of Norwegian breast Cancer patients' experiences with mainstreamed genetic testing
Hered Cancer Clin Pract, 20 (1), 6
DOI 10.1186/s13053-022-00212-6, PubMed 35123550

Stjernberg M, Schlichting E, Rustoen T, Valeberg BT, Småstuen MC, Raeder JC (2021)
Postdischarge pain, nausea and patient satisfaction after diagnostic and breast-conserving ambulatory surgery for breast cancer: A cross-sectional study
Acta Anaesthesiol Scand, 66 (3), 317-325
DOI 10.1111/aas.14015, PubMed 34888855

Rye IH, Huse K, Josefsson SE, Kildal W, Danielsen HE, Schlichting E, Garred Ø, Riis ML, Osbreac, Lingjaerde OC, Myklebust JH, Russnes HG (2021)
Breast cancer metastasis: immune profiling of lymph nodes reveals exhaustion of effector T cells and immunosuppression
Mol Oncol, 16 (1), 88-103
DOI 10.1002/1878-0261.13047, PubMed 34165864

Skjerven HK, Danielsen AS, Schlichting E, Sahlberg KK, Hofvind S (2020)
Surgical treatment of breast cancer in Norway 2003-2018
Tidsskr Nor Laegeforen, 140 (15)
DOI 10.4045/tidsskr.20.0090, PubMed 33118768

Brunvoll SH, Thune I, Bertheussen GF, Fjeldheim F, Flote VG, Frydenberg H, Lundgren S, Skjerven H, Lømo J, Fagerland MW, McTiernan A, Schlichting E, Hjartåker A (2020)
Dietary changes in early-stage breast cancer patients from pre-surgery and over the 12 months post-surgery
Br J Nutr, 125 (2), 172-182
DOI 10.1017/S0007114520002627, PubMed 32811572

von der Lippe Gythfeldt H, Lien T, Tekpli X, Silwal-Pandit L, Borgen E, Garred Ø, Skjerven H, Schlichting E, Lundgren S, Wist E, Naume B, Kristensen V, Børresen-Dale AL, Lingjaerde OC, Engebraaten O (2020)
Immune phenotype of tumor microenvironment predicts response to bevacizumab in neoadjuvant treatment of ER-positive breast cancer
Int J Cancer, 147 (9), 2515-2525
DOI 10.1002/ijc.33108, PubMed 32488909

Grindedal EM, Jørgensen K, Olsson P, Gravdehaug B, Lurås H, Schlichting E, Vamre T, Wangensteen T, Heramb C, Mæhle L (2020)
Mainstreamed genetic testing of breast cancer patients in two hospitals in South Eastern Norway
Fam Cancer, 19 (2), 133-142
DOI 10.1007/s10689-020-00160-x, PubMed 32002722

Sondén ECB, Sebuødegård S, Korvald C, Lømo J, Schlichting E, Brandal SHB, Hofvind S (2020)
[Correction: Cosmetic breast implants and breast cancer]
Tidsskr Nor Laegeforen, 140 (4)
DOI 10.4045/tidsskr.20.0163, PubMed 32192257

Sondén ECB, Sebuødegård S, Korvald C, Lømo J, Schlichting E, Brandal SHB, Hofvind S (2020)
[Cosmetic breast implants and breast cancer]
Tidsskr Nor Laegeforen, 140 (3)
DOI 10.4045/tidsskr.19.0266, PubMed 32105043

Opsahl EM, Akslen LA, Schlichting E, Aas T, Brauckhoff K, Hagen AI, Rosenlund AF, Sigstad E, Grøholt KK, Jørgensen LH, Bjøro T (2019)
The Role of Calcitonin in Predicting the Extent of Surgery in Medullary Thyroid Carcinoma: A Nationwide Population-Based Study in Norway
Eur Thyroid J, 8 (3), 159-166
DOI 10.1159/000499018, PubMed 31259158

Johansson HJ, Socciarelli F, Vacanti NM, Haugen MH, Zhu Y, Siavelis I, Fernandez-Woodbridge A, Aure MR, Sennblad B, Vesterlund M, Branca RM, Orre LM, Huss M, Fredlund E, Beraki E, Garred Ø, Boekel J, Sauer T, Zhao W, Nord S, Höglander EK, Jans DC, Brismar H, Haukaas TH, Bathen TF et al. (2019)
Breast cancer quantitative proteome and proteogenomic landscape
Nat Commun, 10 (1), 1600
DOI 10.1038/s41467-019-09018-y, PubMed 30962452

Hartmann-Johnsen OJ, Kåresen R, Schlichting E, Naume B, Nygård JF (2019)
Using clinical cancer registry data for estimation of quality indicators: Results from the Norwegian breast cancer registry
Int J Med Inform, 125, 102-109
DOI 10.1016/j.ijmedinf.2019.03.004, PubMed 30914174

Höglander EK, Nord S, Wedge DC, Lingjærde OC, Silwal-Pandit L, Gythfeldt HV, Vollan HKM, Fleischer T, Krohn M, Schlitchting E, Borgen E, Garred Ø, Holmen MM, Wist E, Naume B, Van Loo P, Børresen-Dale AL, Engebraaten O, Kristensen V (2018)
Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations
Genome Med, 10 (1), 92
DOI 10.1186/s13073-018-0601-y, PubMed 30497530

Opsahl EM, Akslen LA, Schlichting E, Aas T, Brauckhoff K, Hagen AI, Rosenlund AF, Sigstad E, Grøholt KK, Mæhle L, Engebretsen LF, Jørgensen LH, Varhaug JE, Bjøro T (2018)
Trends in Diagnostics, Surgical Treatment, and Prognostic Factors for Outcomes in Medullary Thyroid Carcinoma in Norway: A Nationwide Population-Based Study
Eur Thyroid J, 8 (1), 31-40
DOI 10.1159/000493977, PubMed 30800639

Brunvoll SH, Thune I, Frydenberg H, Flote VG, Bertheussen GF, Schlichting E, Bjerve KS, Hjartåker A (2018)
Validation of repeated self-reported n-3 PUFA intake using serum phospholipid fatty acids as a biomarker in breast cancer patients during treatment
Nutr J, 17 (1), 94
DOI 10.1186/s12937-018-0402-6, PubMed 30333016

Borgen E, Rypdal MC, Sosa MS, Renolen A, Schlichting E, Lønning PE, Synnestvedt M, Aguirre-Ghiso JA, Naume B (2018)
NR2F1 stratifies dormant disseminated tumor cells in breast cancer patients
Breast Cancer Res, 20 (1), 120
DOI 10.1186/s13058-018-1049-0, PubMed 30322396

Madssen TS, Thune I, Flote VG, Lundgren S, Bertheussen GF, Frydenberg H, Wist E, Schlichting E, Schäfer H, Fjøsne HE, Vettukattil R, Lømo J, Bathen TF, Giskeødegård GF (2018)
Metabolite and lipoprotein responses and prediction of weight gain during breast cancer treatment
Br J Cancer, 119 (9), 1144-1154
DOI 10.1038/s41416-018-0211-x, PubMed 30401977

Tinholt M, Garred Ø, Borgen E, Beraki E, Schlichting E, Kristensen V, Sahlberg KK, Iversen N (2018)
Subtype-specific clinical and prognostic relevance of tumor-expressed F5 and regulatory F5 variants in breast cancer: the CoCaV study
J Thromb Haemost, 16 (7), 1347-1356
DOI 10.1111/jth.14151, PubMed 29766637

Moberg IO, Schou Bredal I, Schneider MR, Tønseth KA, Schlichting E (2018)
Complications, risk factors, and patients-reported outcomes after skin-sparing mastectomy followed by breast reconstruction in women with BRCA mutations
J Plast Surg Hand Surg, 52 (4), 234-239
DOI 10.1080/2000656X.2018.1470093, PubMed 29741462

Norum J, Grindedal EM, Heramb C, Karsrud I, Ariansen SL, Undlien DE, Schlichting E, Mæhle L (2018)
BRCA mutation carrier detection. A model-based cost-effectiveness analysis comparing the traditional family history approach and the testing of all patients with breast cancer
ESMO Open, 3 (3), e000328
DOI 10.1136/esmoopen-2018-000328, PubMed 29682331

Ohnstad HO, Borgen E, Falk RS, Lien TG, Aaserud M, Sveli MAT, Kyte JA, Kristensen VN, Geitvik GA, Schlichting E, Wist EA, Sørlie T, Russnes HG, Naume B (2017)
Prognostic value of PAM50 and risk of recurrence score in patients with early-stage breast cancer with long-term follow-up
Breast Cancer Res, 19 (1), 120
DOI 10.1186/s13058-017-0911-9, PubMed 29137653

Fleischer T, Tekpli X, Mathelier A, Wang S, Nebdal D, Dhakal HP, Sahlberg KK, Schlichting E, Oslo Breast Cancer Research Consortium (OSBREAC), Børresen-Dale AL, Borgen E, Naume B, Eskeland R, Frigessi A, Tost J, Hurtado A, Kristensen VN (2017)
DNA methylation at enhancers identifies distinct breast cancer lineages
Nat Commun, 8 (1), 1379
DOI 10.1038/s41467-017-00510-x, PubMed 29123100

Dumeaux V, Fjukstad B, Fjosne HE, Frantzen JO, Holmen MM, Rodegerdts E, Schlichting E, Børresen-Dale AL, Bongo LA, Lund E, Hallett M (2017)
Interactions between the tumor and the blood systemic response of breast cancer patients
PLoS Comput Biol, 13 (9), e1005680
DOI 10.1371/journal.pcbi.1005680, PubMed 28957325

Hartmann-Johnsen OJ, Kåresen R, Schlichting E, Nygård JF (2017)
Better survival after breast-conserving therapy compared to mastectomy when axillary node status is positive in early-stage breast cancer: a registry-based follow-up study of 6387 Norwegian women participating in screening, primarily operated between 1998 and 2009
World J Surg Oncol, 15 (1), 118
DOI 10.1186/s12957-017-1184-6, PubMed 28673296

Grindedal EM, Heramb C, Karsrud I, Ariansen SL, Mæhle L, Undlien DE, Norum J, Schlichting E (2017)
Current guidelines for BRCA testing of breast cancer patients are insufficient to detect all mutation carriers
BMC Cancer, 17 (1), 438
DOI 10.1186/s12885-017-3422-2, PubMed 28637432

Silwal-Pandit L, Nord S, von der Lippe Gythfeldt H, Møller EK, Fleischer T, Rødland E, Krohn M, Borgen E, Garred Ø, Olsen T, Vu P, Skjerven H, Fangberget A, Holmen MM, Schlitchting E, Wille E, Nordberg Stokke M, Moen Vollan HK, Kristensen V, Langerød A, Lundgren S, Wist E, Naume B, Lingjærde OC, Børresen-Dale AL et al. (2017)
The Longitudinal Transcriptional Response to Neoadjuvant Chemotherapy with and without Bevacizumab in Breast Cancer
Clin Cancer Res, 23 (16), 4662-4670
DOI 10.1158/1078-0432.CCR-17-0160, PubMed 28487444

Vaysse C, Lømo J, Garred Ø, Fjeldheim F, Lofteroed T, Schlichting E, McTiernan A, Frydenberg H, Husøy A, Lundgren S, Fagerland MW, Richardsen E, Wist EA, Muller C, Thune I (2017)
Inflammation of mammary adipose tissue occurs in overweight and obese patients exhibiting early-stage breast cancer
NPJ Breast Cancer, 3, 19
DOI 10.1038/s41523-017-0015-9, PubMed 28649659

Aure MR, Vitelli V, Jernström S, Kumar S, Krohn M, Due EU, Haukaas TH, Leivonen SK, Vollan HK, Lüders T, Rødland E, Vaske CJ, Zhao W, Møller EK, Nord S, Giskeødegård GF, Bathen TF, Caldas C, Tramm T, Alsner J, Overgaard J, Geisler J, Bukholm IR, Naume B, Schlichting E et al. (2017)
Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome
Breast Cancer Res, 19 (1), 44
DOI 10.1186/s13058-017-0812-y, PubMed 28356166

Opsahl EM, Brauckhoff M, Schlichting E, Helset K, Svartberg J, Brauckhoff K, Mæhle L, Engebretsen LF, Sigstad E, Grøholt KK, Akslen LA, Jørgensen LH, Varhaug JE, Bjøro T (2016)
A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma
Thyroid, 26 (9), 1225-38
DOI 10.1089/thy.2015.0673, PubMed 27400880

Haukaas TH, Euceda LR, Giskeødegård GF, Lamichhane S, Krohn M, Jernström S, Aure MR, Lingjærde OC, Schlichting E, Garred Ø, Due EU, Mills GB, Sahlberg KK, Børresen-Dale AL, Bathen TF, Oslo Breast Cancer Consortium (OSBREAC) (2016)
Metabolic clusters of breast cancer in relation to gene- and protein expression subtypes
Cancer Metab, 4, 12
DOI 10.1186/s40170-016-0152-x, PubMed 27350877

Flote VG, Vettukattil R, Bathen TF, Egeland T, McTiernan A, Frydenberg H, Husøy A, Finstad SE, Lømo J, Garred Ø, Schlichting E, Wist EA, Thune I (2016)
Lipoprotein subfractions by nuclear magnetic resonance are associated with tumor characteristics in breast cancer
Lipids Health Dis, 15, 56
DOI 10.1186/s12944-016-0225-4, PubMed 26970778

Silwal-Pandit L, Russnes H, Borgen E, Skarpeteig V, Moen Vollan HK, Schlichting E, Kåresen R, Naume B, Børresen-Dale AL, Farnebo M, Langerød A (2015)
The Sub-Cellular Localization of WRAP53 Has Prognostic Impact in Breast Cancer
PLoS One, 10 (10), e0139965
DOI 10.1371/journal.pone.0139965, PubMed 26460974

Hartmann-Johnsen OJ, Kåresen R, Schlichting E, Nygård JF (2015)
Survival is Better After Breast Conserving Therapy than Mastectomy for Early Stage Breast Cancer: A Registry-Based Follow-up Study of Norwegian Women Primary Operated Between 1998 and 2008
Ann Surg Oncol, 22 (12), 3836-45
DOI 10.1245/s10434-015-4441-3, PubMed 25743325

Tinholt M, Viken MK, Dahm AE, Vollan HK, Sahlberg KK, Garred O, Børresen-Dale AL, Jacobsen AF, Kristensen V, Bukholm I, Kåresen R, Schlichting E, Skretting G, Lie BA, Sandset PM, Iversen N (2014)
Increased coagulation activity and genetic polymorphisms in the F5, F10 and EPCR genes are associated with breast cancer: a case-control study
BMC Cancer, 14, 845
DOI 10.1186/1471-2407-14-845, PubMed 25407022

Dumeaux V, Ursini-Siegel J, Flatberg A, Fjosne HE, Frantzen JO, Holmen MM, Rodegerdts E, Schlichting E, Lund E (2014)
Peripheral blood cells inform on the presence of breast cancer: a population-based case-control study
Int J Cancer, 136 (3), 656-67
DOI 10.1002/ijc.29030, PubMed 24931809

Frydenberg H, Flote VG, Iversen A, Finstad SE, Furberg AS, Torjesen PA, Wilsgaard T, Schlichting E, Ellison PT, Ursin G, Thune I (2014)
Insulin-like growth factor-1, growth hormone, and daily cycling estrogen are associated with mammographic density in premenopausal women
Cancer Causes Control, 25 (7), 891-903
DOI 10.1007/s10552-014-0389-z, PubMed 24801047

Schou Bredal I, Smeby NA, Ottesen S, Warncke T, Schlichting E (2014)
Chronic pain in breast cancer survivors: comparison of psychosocial, surgical, and medical characteristics between survivors with and without pain
J Pain Symptom Manage, 48 (5), 852-62
DOI 10.1016/j.jpainsymman.2013.12.239, PubMed 24703940

Hagen AI, Mæhle L, Vedå N, Vetti HH, Stormorken A, Ludvigsen T, Guntvedt B, Isern AE, Schlichting E, Kleppe G, Bofin A, Gullestad HP, Møller P (2013)
Risk reducing mastectomy, breast reconstruction and patient satisfaction in Norwegian BRCA1/2 mutation carriers
Breast, 23 (1), 38-43
DOI 10.1016/j.breast.2013.10.002, PubMed 24210736

Hannisdal E, Arianson H, Braut GS, Schlichting E, Vinnem JE (2013)
A risk analysis of cancer care in Norway: the top 16 patient safety hazards
Jt Comm J Qual Patient Saf, 39 (11), 511-6
DOI 10.1016/s1553-7250(13)39067-9, PubMed 24294679

Hofvind S, Schlichting E, Ursin G, Sebuødegård S, Kåresen R (2013)
[Breast cancer surgery in Norway 1986-2009]
Tidsskr Nor Laegeforen, 133 (15), 1582-6
DOI 10.4045/tidsskr.12.0840, PubMed 23970271

Synnestvedt M, Borgen E, Schlichting E, Schirmer CB, Renolen A, Giercksky KE, Nesland JM, Naume B (2013)
Disseminated tumour cells in the bone marrow in early breast cancer: morphological categories of immunocytochemically positive cells have different impact on clinical outcome
Breast Cancer Res Treat, 138 (2), 485-97
DOI 10.1007/s10549-013-2439-8, PubMed 23456230

Dhakal HP, Naume B, Synnestvedt M, Borgen E, Kaaresen R, Schlichting E, Wiedswang G, Bassarova A, Holm R, Giercksky KE, Nesland JM (2012)
Expression of cyclooxygenase-2 in invasive breast carcinomas and its prognostic impact
Histol Histopathol, 27 (10), 1315-25
DOI 10.14670/HH-27.1315, PubMed 22936450

Synnestvedt M, Borgen E, Russnes HG, Kumar NT, Schlichting E, Giercksky KE, Kåresen R, Nesland JM, Naume B (2012)
Combined analysis of vascular invasion, grade, HER2 and Ki67 expression identifies early breast cancer patients with questionable benefit of systemic adjuvant therapy
Acta Oncol, 52 (1), 91-101
DOI 10.3109/0284186X.2012.713508, PubMed 22934555

Dhakal HP, Naume B, Synnestvedt M, Borgen E, Kaaresen R, Schlichting E, Wiedswang G, Bassarova A, Holm R, Giercksky KE, Nesland JM (2012)
Expression of vascular endothelial growth factor and vascular endothelial growth factor receptors 1 and 2 in invasive breast carcinoma: prognostic significance and relationship with markers for aggressiveness
Histopathology, 61 (3), 350-64
DOI 10.1111/j.1365-2559.2012.04223.x, PubMed 22690749

Suhrke P, Mæhlen J, Schlichting E, Jørgensen KJ, Gøtzsche PC, Zahl PH (2011)
Effect of mammography screening on surgical treatment for breast cancer in Norway: comparative analysis of cancer registry data
BMJ, 343, d4692
DOI 10.1136/bmj.d4692, PubMed 21914765

Borgan E, Navon R, Vollan HK, Schlichting E, Sauer T, Yakhini Z, Lingjærde OC, Sørlie T, Børresen-Dale AL (2011)
Ischemia caused by time to freezing induces systematic microRNA and mRNA responses in cancer tissue
Mol Oncol, 5 (6), 564-76
DOI 10.1016/j.molonc.2011.08.004, PubMed 21917534

Molloy TJ, Bosma AJ, Baumbusch LO, Synnestvedt M, Borgen E, Russnes HG, Schlichting E, van't Veer LJ, Naume B (2011)
The prognostic significance of tumour cell detection in the peripheral blood versus the bone marrow in 733 early-stage breast cancer patients
Breast Cancer Res, 13 (3), R61
DOI 10.1186/bcr2898, PubMed 21672237

Chrisanthar R, Knappskog S, Løkkevik E, Anker G, Ostenstad B, Lundgren S, Risberg T, Mjaaland I, Skjønsberg G, Aas T, Schlichting E, Fjösne HE, Nysted A, Lillehaug JR, Lønning PE (2011)
Predictive and prognostic impact of TP53 mutations and MDM2 promoter genotype in primary breast cancer patients treated with epirubicin or paclitaxel
PLoS One, 6 (4), e19249
DOI 10.1371/journal.pone.0019249, PubMed 21556366

Kamalakaran S, Varadan V, Giercksky Russnes HE, Levy D, Kendall J, Janevski A, Riggs M, Banerjee N, Synnestvedt M, Schlichting E, Kåresen R, Shama Prasada K, Rotti H, Rao R, Rao L, Eric Tang MH, Satyamoorthy K, Lucito R, Wigler M, Dimitrova N, Naume B, Borresen-Dale AL, Hicks JB (2010)
DNA methylation patterns in luminal breast cancers differ from non-luminal subtypes and can identify relapse risk independent of other clinical variables
Mol Oncol, 5 (1), 77-92
DOI 10.1016/j.molonc.2010.11.002, PubMed 21169070

Russnes HG, Vollan HKM, Lingjærde OC, Krasnitz A, Lundin P, Naume B, Sørlie T, Borgen E, Rye IH, Langerød A, Chin SF, Teschendorff AE, Stephens PJ, Månér S, Schlichting E, Baumbusch LO, Kåresen R, Stratton MP, Wigler M, Caldas C, Zetterberg A, Hicks J, Børresen-Dale AL (2010)
Genomic architecture characterizes tumor progression paths and fate in breast cancer patients
Sci Transl Med, 2 (38), 38ra47
DOI 10.1126/scitranslmed.3000611, PubMed 20592421

Emaus A, Veierød MB, Tretli S, Finstad SE, Selmer R, Furberg AS, Bernstein L, Schlichting E, Thune I (2009)
Metabolic profile, physical activity, and mortality in breast cancer patients
Breast Cancer Res Treat, 121 (3), 651-60
DOI 10.1007/s10549-009-0603-y, PubMed 19882245

Dhakal HP, Bassarova A, Naume B, Synnestvedt M, Borgen E, Kaaresen R, Schlichting E, Wiedswang G, Giercksky KE, Nesland JM (2009)
Breast carcinoma vascularity: a comparison of manual microvessel count and Chalkley count
Histol Histopathol, 24 (8), 1049-59
DOI 10.14670/HH-24.1049, PubMed 19554512

Dhakal HP, Naume B, Synnestvedt M, Borgen E, Kaaresen R, Schlichting E, Wiedswang G, Bassarova A, Giercksky KE, Nesland JM (2008)
Vascularization in primary breast carcinomas: its prognostic significance and relationship with tumor cell dissemination
Clin Cancer Res, 14 (8), 2341-50
DOI 10.1158/1078-0432.CCR-07-4214, PubMed 18413823

Schlichting E, Nielsen HB, Fosså SD, Aasland OG (2007)
[Women's academic careers in medicine]
Tidsskr Nor Laegeforen, 127 (16), 2109-12
PubMed 17717577

Hval K, Thagaard KS, Schlichting E, Raeder J (2007)
The prolonged postoperative analgesic effect when dexamethasone is added to a nonsteroidal antiinflammatory drug (rofecoxib) before breast surgery
Anesth Analg, 105 (2), 481-6
DOI 10.1213/01.ane.0000267261.61444.69, PubMed 17646509

Geisler J, Lønning PE, Krag LE, Løkkevik E, Risberg T, Hagen AI, Schlichting E, Lien EA, Ofjord ES, Eide GE, Polli A, di Salle E, Paolini J (2006)
Changes in bone and lipid metabolism in postmenopausal women with early breast cancer after terminating 2-year treatment with exemestane: a randomised, placebo-controlled study
Eur J Cancer, 42 (17), 2968-75
DOI 10.1016/j.ejca.2006.07.005, PubMed 16963261

Schlichting E, Harr ME, Sauer T, Babovic A, Kåresen R (2006)
[Sentinel lymph node biopsy in breast cancer]
Tidsskr Nor Laegeforen, 126 (16), 2098-100
PubMed 16932777

Lønning PE, Geisler J, Krag LE, Erikstein B, Bremnes Y, Hagen AI, Schlichting E, Lien EA, Ofjord ES, Paolini J, Polli A, Massimini G (2005)
Effects of exemestane administered for 2 years versus placebo on bone mineral density, bone biomarkers, and plasma lipids in patients with surgically resected early breast cancer
J Clin Oncol, 23 (22), 5126-37
DOI 10.1200/JCO.2005.07.097, PubMed 15983390

Sharma P, Sahni NS, Tibshirani R, Skaane P, Urdal P, Berghagen H, Jensen M, Kristiansen L, Moen C, Sharma P, Zaka A, Arnes J, Sauer T, Akslen LA, Schlichting E, Børresen-Dale AL, Lönneborg A (2005)
Early detection of breast cancer based on gene-expression patterns in peripheral blood cells
Breast Cancer Res, 7 (5), R634-44
DOI 10.1186/bcr1203, PubMed 16168108

Wiedswang G, Borgen E, Kåresen R, Kvalheim G, Nesland JM, Qvist H, Schlichting E, Sauer T, Janbu J, Harbitz T, Naume B (2003)
Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer
J Clin Oncol, 21 (18), 3469-78
DOI 10.1200/JCO.2003.02.009, PubMed 12972522

Kåresen R, Hervik A, Schlichting E (2003)
[Medical logistics: principles applied to diagnostics and therapy in women with symptoms and signs of breast cancer]
Tidsskr Nor Laegeforen, 123 (12), 1687-90
PubMed 12821992

Sauer T, Engh V, Holck AM, Sørpebøl G, Heim M, Furu I, Schlichting E (2003)
Imprint cytology of sentinel lymph nodes in breast cancer. Experience with rapid, intraoperative diagnosis and primary screening by cytotechnologists
Acta Cytol, 47 (5), 768-73
DOI 10.1159/000326603, PubMed 14526676

Lønning PE, Kragh LE, Erikstein B, Hagen A, Risberg T, Schlichting E, Geisler J (2001)
The potential for aromatase inhibition in breast cancer prevention
Clin Cancer Res, 7 (12 Suppl), 4423s-4428s; discussion 4411s-4412s
PubMed 11916235

Kutzsche S, Schlichting E, Aspelin T, Lyberg T (2000)
Hemodynamic changes and systemic activation of coagulation and fibrinolysis during controlled endotoxemia in pigs
Thromb Res, 98 (6), 517-29
DOI 10.1016/s0049-3848(00)00189-4, PubMed 10899351

Schlichting E, Babovic A, Kåresen R (1999)
[Sentinel lymph node]
Tidsskr Nor Laegeforen, 119 (14), 2009
PubMed 10394273

Enger H, Pettersen EH, Schlichting E, Kåresen R, Guldvog I, Sauer T (1998)
[Breast conserving surgery for breast cancer--local recurrence]
Tidsskr Nor Laegeforen, 118 (21), 3262-5
PubMed 9772812

Borgen E, Beiske K, Trachsel S, Nesland JM, Kvalheim G, Herstad TK, Schlichting E, Qvist H, Naume B (1998)
Immunocytochemical detection of isolated epithelial cells in bone marrow: non-specific staining and contribution by plasma cells directly reactive to alkaline phosphatase
J Pathol, 185 (4), 427-34
DOI 10.1002/(SICI)1096-9896(199808)185:4<427::AID-PATH127>3.0.CO;2-7, PubMed 9828843

Schlichting E, Carlsen E (1998)
[Introduction of a new surgical technique in rectal cancer]
Tidsskr Nor Laegeforen, 118 (12), 1846-9
PubMed 9638050

Carlsen E, Schlichting E, Guldvog I, Johnson E, Heald RJ (1998)
Effect of the introduction of total mesorectal excision for the treatment of rectal cancer
Br J Surg, 85 (4), 526-9
DOI 10.1046/j.1365-2168.1998.00601.x, PubMed 9607540

Schlichting E, Solhaug JH (1996)
[Lack of specialists in gastroenterological surgery]
Tidsskr Nor Laegeforen, 116 (28), 3352-3
PubMed 9011994

Schlichting E, Aspelin T, Lyberg T (1996)
Interactions of endotoxin with human blood cells and serum proteins
Scand J Clin Lab Invest, 56 (2), 167-76
DOI 10.3109/00365519609088604, PubMed 8743110

Schlichting E, Lyberg T (1995)
Monitoring of tissue oxygenation in shock: an experimental study in pigs
Crit Care Med, 23 (10), 1703-10
DOI 10.1097/00003246-199510000-00015, PubMed 7587236

Tønnessen T, Schlichting E, Lyberg T, Christensen G (1995)
Endothelin release associated with splanchnic ischemia is abolished by inhibition of leukocyte-derived proteases
Endothelium, 3, 225-234
DOI 10.3109/10623329509024668, PublikaID 318

Schlichting E, Grotmol T, Kähler H, Naess O, Steinbakk M, Lyberg T (1995)
Alterations in mucosal morphology and permeability, but no bacterial or endotoxin translocation takes place after intestinal ischemia and early reperfusion in pigs
Shock, 3 (2), 116-24
DOI 10.1097/00024382-199503020-00006, PubMed 7749938

Schlichting E, Aspelin T, Grotmol T, Lyberg T (1995)
Endothelin and hemodynamic responses to superior mesenteric artery occlusion shock and hemorrhagic shock in pigs
Shock, 3 (2), 109-15
DOI 10.1097/00024382-199503020-00005, PubMed 7749937

Ostenstad B, Sioud M, Schlichting E, Lea T, Harboe M (1995)
Freshly isolated tumour-infiltrating T-lymphocytes have a high cytotoxic potential, as measured by their ability to induce apoptosis in the target cell
Scand J Immunol, 41 (1), 42-8
DOI 10.1111/j.1365-3083.1995.tb03531.x, PubMed 7824887

Schlichting E, Henriksen T, Lyberg T (1994)
Lipoproteins do not modulate the tissue factor activity, plasminogen activator or tumour necrosis factor production induced by lipopolysaccharide stimulation of human monocytes
Scand J Clin Lab Invest, 54 (6), 465-73
DOI 10.3109/00365519409085471, PubMed 7809580

Ostenstad B, Sioud M, Lea T, Schlichting E, Harboe M (1994)
Limited heterogeneity in the T-cell receptor V-gene usage in lymphocytes infiltrating human colorectal tumours
Br J Cancer, 69 (6), 1078-82
DOI 10.1038/bjc.1994.211, PubMed 8198973

Kristo C, Schlichting E, Buanes T (1994)
[Surgical treatment of gastrointestinal malignant melanoma]
Tidsskr Nor Laegeforen, 114 (8), 912-4
PubMed 8191466

Ostenstad B, Lea T, Schlichting E, Harboe M (1994)
Human colorectal tumour infiltrating lymphocytes express activation markers and the CD45RO molecule, showing a primed population of lymphocytes in the tumour area
Gut, 35 (3), 382-7
DOI 10.1136/gut.35.3.382, PubMed 8150352

Schlichting E, Clausen OP, Hanssen AS, Buanes TA (1993)
Ploidy and survival in resectable pancreatic cancers. A retrospective study over 9 years
Eur J Surg, 159 (4), 229-33
PubMed 8102544

Schlichting E, Lyberg T, Solberg O, Andersen BM (1993)
Endotoxin liberation from Neisseria meningitidis correlates to their ability to induce procoagulant and fibrinolytic factors in human monocytes
Scand J Infect Dis, 25 (5), 585-94
DOI 10.3109/00365549309008547, PubMed 8284643

Meling GI, Rognum TO, Clausen OP, Børmer O, Lunde OC, Schlichting E, Grüner OP, Hognestad J, Trondsen E, Havig O (1992)
Serum carcinoembryonic antigen in relation to survival, DNA ploidy pattern, and recurrent disease in 406 colorectal carcinoma patients
Scand J Gastroenterol, 27 (12), 1061-8
DOI 10.3109/00365529209028139, PubMed 1475624

Graadal O, Schlichting E, Solheim K, Serck-Hanssen A (1992)
[Pseudomembranous colitis. Surgical treatment]
Tidsskr Nor Laegeforen, 112 (21), 2753-4
PubMed 1412307

Schlichting E, Lyberg T, Solheim K (1992)
[Indirect measurement of intramucosal pH in the gastrointestinal tract using a tonometer. A useful marker of tissue oxygenation in critically ill patients]
Tidsskr Nor Laegeforen, 112 (16), 2096-9
PubMed 1523632

Meling GI, Rognum TO, Clausen OP, Chen Y, Lunde OC, Schlichting E, Wiig JN, Hognestad J, Bakka A, Havig O (1991)
Association between DNA ploidy pattern and cellular atypia in colorectal carcinomas. A new clinical application of DNA flow cytometric study?
Cancer, 67 (6), 1642-9
DOI 10.1002/1097-0142(19910315)67:6<1642::aid-cncr2820670628>3.0.co;2-r, PubMed 2001553

Graadal O, Schlichting E, Aasen AO, Stadaas JO (1990)
[Use of resources in the treatment of pancreatic cancer]
Tidsskr Nor Laegeforen, 110 (23), 2981-2
PubMed 1700495

Graadal O, Schlichting E, Aasen AO, Stadaas JO (1990)
[Study and diagnosis of pancreatic cancer]
Tidsskr Nor Laegeforen, 110 (23), 2979-80
PubMed 2237845

Schlichting E, Graadal O, Aasen AO, Stadaas JO (1990)
[Pancreatic cancer. Treatment and results]
Tidsskr Nor Laegeforen, 110 (23), 2974-8
PubMed 1700494

Berg T, Schlichting E, Ishida H, Carretero OA (1989)
Kinin antagonist does not protect against the hypotensive response to endotoxin, anaphylaxis or acute pancreatitis
J Pharmacol Exp Ther, 251 (2), 731-4
PubMed 2810121

Sletnes KE, Wisløff F, Schlichting E, Kåresen R (1989)
[Splenectomy in hematologic diseases]
Tidsskr Nor Laegeforen, 109 (2), 201-3
PubMed 2916199

Schlichting E, Buanes T, Stadaas JO (1988)
[Gallbladder cancer. Occurrence, diagnosis, treatment and prognosis]
Tidsskr Nor Laegeforen, 108 (10), 733-5
PubMed 3363543

Schlichting E, Solheim K, Kåresen R (1988)
[Splenectomy. Indications and complications]
Tidsskr Nor Laegeforen, 108 (2), 127-9
PubMed 3353908

Review articles

Banys-Paluchowski M, Gasparri ML, de Boniface J, Gentilini O, Stickeler E, Hartmann S, Thill M, Rubio IT, Di Micco R, Bonci EA, Niinikoski L, Kontos M, Karadeniz Cakmak G, Hauptmann M, Peintinger F, Pinto D, Matrai Z, Murawa D, Kadayaprath G, Dostalek L, Nina H, Krivorotko P, Classe JM, Schlichting E, Appelgren M et al. (2021)
Surgical Management of the Axilla in Clinically Node-Positive Breast Cancer Patients Converting to Clinical Node Negativity through Neoadjuvant Chemotherapy: Current Status, Knowledge Gaps, and Rationale for the EUBREAST-03 AXSANA Study
Cancers (Basel), 13 (7)
DOI 10.3390/cancers13071565, PubMed 33805367

Kåresen R, Jensen HH, Sauer T, Schlichting E, Skaane P, Wang H (2002)
Logistics of referral, diagnostic assessment and treatment of patients with breast symptoms and signs
Scand J Surg, 91 (3), 232-8
DOI 10.1177/145749690209100304, PubMed 12449464

Hovdenak N, Schlichting E (1998)
[Inflammatory bowel disease and pregnancy]
Tidsskr Nor Laegeforen, 118 (8), 1201-3
PubMed 9567697

Schlichting E, Andersen BM (1998)
[Prevention of infections among surgeons]
Tidsskr Nor Laegeforen, 118 (3), 416-8
PubMed 9499733